Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury
This completed clinical trial analyzed single-cell and spatial transcriptomics to investigate how steatotic donor livers are susceptible to …
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity [NA]
This clinical trial update notes the completion of a study evaluating whether lifestyle intervention can mobilize fat storage and iron depos…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective Study
This clinical trial update reports results from a 10-year prospective study using ultrasound to assess atherosclerotic plaque burden and its…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway
A completed UT Southwestern clinical trial examined how fatty liver affects mitochondrial TCA cycle flux and the pentose phosphate pathway.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Metabolic Changes in Healthy Subjects with Acute Binge Drink [Phase 1]
Phase 1 clinical trial investigating metabolic changes in healthy subjects following acute binge drinking. The study has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
This is a clinical trial update for NCT06691529 studying Metabolic Associated Fatty Liver Disease in patients with chronic glomerular diseas…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism [Phase 4]
Phase 4 clinical trial evaluating testosterone undecanoate versus placebo on intrahepatic fat content in overweight/obese men with type 2 di…
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) [Phase 2]
Phase 2 clinical trial investigating the potential benefits of itopride for metabolic-associated fatty liver disease (MAFLD).
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluating probiotics for non-alcoholic fatty liver disease and steatohepatitis; results have been pos…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis [Phase 2]
Phase 2 trial evaluating nitazoxanide for safety and efficacy in reducing collagen turnover in NASH patients with fibrosis; study completed …
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease [Phase 3]
Phase 3 randomized trial evaluating dapagliflozin in fatty liver disease; status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH [Phase 2]
Phase 2 trial evaluating MET409 alone or with empagliflozin in patients with type 2 diabetes and nonalcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 clinical trial of Siliphos in adults with fatty liver (NASH) completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E [Phase 2]
Phase 2 trial evaluating different doses of vitamin E for treatment of fatty liver disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease [EARLY_Phase 1]
Early-phase liver PET study on non-alcoholic fatty liver disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: MRI to Measure Liver Fat Content [NA]
This clinical trial update notes completion of a study using MRI to measure liver fat content. Conditions include fatty liver disease and he…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement [NA]
This completed clinical trial evaluated a three-dimensional force-controlled ultrasound method for assessing fatty liver in patients, with r…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes [Phase 3]
Phase 3 trial of rimonabant for nonalcoholic steatohepatitis in non-diabetic patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition [NA]
This clinical trial update notes that a randomized study evaluating intravenous choline supplementation in long-term total parenteral nutrit…
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections [Phase 4]
A Phase 4 trial evaluating pioglitazone for fatty liver disease in patients with HIV and hepatitis C was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease [Phase 2]
Phase 2 trial assessing GWP42003 effects on liver fat in fatty liver disease completed with posted results.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Omega 3 Supplementation in Fatty Liver [Phase 3]
Phase 3 trial evaluating omega-3 fatty acid supplementation for fatty liver has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications
This clinical trial update reports on a completed study using MRI to quantify liver fat to predict postoperative complications.
-
CLINICAL_TRIALS trial_result · 2008-08-12Clinical Trial Update: Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content [NA]
The clinical trial evaluates growth hormone during fasting and its effects on signaling in muscle and adipose tissue as well as intrahepatic…